PE/VC investors
Private Equity (PE) and Venture Capital (VC) investors are the catalysts of innovation and growth in the business world. PE firms primarily target established companies, seeking to optimize operations and unlock value through strategic investments and management expertise. They focus on long-term growth and profitability, often preparing businesses for a future sale or IPO. VC investors, by contrast, are the adventurers of finance, injecting capital into high-potential startups and early-stage companies. They embrace risk for the possibility of outsized returns, often becoming invaluable advisors. Both investor types not only bring capital but also strategic guidance, industry connections, and market insights, propelling their portfolio companies towards success.
Investors (6,250)
Investor
Description
More information
Boulder Ventures
Boulder Ventures is a specialty venture capital firm, investing in a niche geography, leveraging decades long relationships with proven entrepreneurs and evaluating early stage companies with deep technical and scientific expertise.
<br />
<br />
We spend time and energy cultivating a network of serial entrepreneurs, because they are the source of Boulder Ventures investment ideas. Our serial entrepreneurs are subject matter experts. They consistently hatch market-leading ideas in information technology and life sciences that develop into market-leading companies in software, networking, data storage, drug discovery and tools, and technology enabled services.
<br />
Boundary Holding
![Boundary Holding]()
Boundary Holding is an European investment fund with presence in Luxembourg and France that invests in Artificial Intelligence, and its associated verticals such as IoT and Analytics. Founded by Rajat Khare, Boundary Holding operates as a bridge fund to help companies to move towards Series A, or in between any other rounds where financing is required in the form of an investment. The fund is associated with various startup programs in Europe, and around the world across different organizations. The company looks forward to investing in efficient business models of startups in the associated next-gen technologies, which has the potential to further grab market opportunities, whilst maintaining allegiance towards the entrepreneurial roots and ideals.
Bourne Avenue Capital Partners
Bourne Avenue Capital Partners is a real estate investment firm seeking opportunities to invest in real estate assets. We bring a wealth of sophisticated real estate and investment experience to the commercial real estate market.
Bowery Capital
![Bowery Capital]()
Bowery Capital is an early-stage venture capital investor focused exclusively on founders looking to modernize business through technology. As more and more internet natives drive purchasing decisions, Bowery Capital believes that roughly $468B will change hands over the next 10 years as old products are replaced with new. In addition, the firm believes that the key ingredient to early success is revenue and customer growth, and as such provides various products and services through their Acceleration Team that portfolio companies can leverage to develop a strong early base. This combination of a focused thesis and support system are the cornerstones of Bowery Capital's investment approach
Bowmark Capital
Bowmark Capital is a leading private equity investment firm, specialising in UK growth companies valued at up to $250 million. We are supportive investors, backing experienced management teams to build world class businesses. Our team has extensive experience of investing in growth companies, having supported over 70 businesses across a range of industries, including Business & Financial Services, Consumer & Leisure, Education & Training, Healthcare, Media and Technology. Our philosophy is to be creative and responsive partners, tailoring our involvement to the needs of each company.
Boxer Capital
![Boxer Capital]()
Boxer Capital, LLC, is a private biotechnology investment fund based in San Diego, California that invents and invests in new therapeutics across multiple indications in order to create value through improved patient care and outcomes. Founded in 2005, Boxer Capital invests in private and public companies representing the entire drug development lifecycle - from early-stage pre-clinical discovery assets to late-stage clinical and commercial stage companies.
Through disciplined analysis, our research and investment team identify opportunities to invest throughout the business life-cycle - from long term positions with mature biotechnology companies that have strong leadership and high growth potential, to building new biotechnology companies from the ground up.
Our expert team includes scientists and clinicians who have been at the forefront of research and discovery across multiple therapeutic indications, including cardiovascular health, oncology, and neurological disease. Several members of our team continue to practice medicine and have had the privilege of leading clinical development for multiple drugs that are treating patients today.
BoxGroup
![BoxGroup]()
Before there is a company, there is a conversation - we want to be that first conversation
Early Stage
We invest as early as the pre-seed round and as late as Series A. We reserve capital to follow-on as you scale.
Made in NYC
NYC is our home and we are proud of it. We have a deep network here, but fund companies anywhere.
$250K-750K Checks
We want to be your first commitment. We don't believe in sharp elbows and invest alongside other investors.
To The Moon
Tech has evolved from a vertical to a horizontal changing every industry. We back founders that dream about things the world has never seen.
Friend in the Room
We believe in honesty and tough love in building relationships with founders. We have your back. WYSIWYG.
Values
We partner with entrepreneurs who value integrity, curiosity, and ambition.
Early stage fundraising has taken on many names - friends & family round, pre-seed, seed, etc and we're open to all of them. We're comfortable with what early means - a lot of assumptions, more vision than traction, and raw product.
We support companies based on conviction in the team. We believe in "founder market fit" - the concept that certain teams are able to unlock specific markets. This is the first step to get to "product market fit." Ideas tend not to be equal opportunity which means that it requires the right team to bring a vision to life.
We hope technology can be a catalyst for positive change and progress. We look for entrepreneurs working at the beginning of movements in existing markets or new markets yet to be created and with visions to create the next generation of category defining businesses.
Lastly, companies are borne out of leadership. The strongest leaders display paired values and we seek out: humility with audacity, genius with hustle, curiosity with authenticity, honesty with salesmanship, and wacky with pragmatic.
BoxGroup
Our goal at BoxGroup is to invest at the earliest stage. Early stage fundraising has taken on many names— friends & family round, pre-seed, seed, etc. and we're open to all of them. We're comfortable with what early means— a lot of assumptions, more vision than traction, and raw product. At BoxGroup we believe that technology can be a catalyst for positive change and progress. We look for entrepreneurs working at the beginning of movements in existing markets, or new markets yet to be created, and with visions to create the next generation of category defining businesses.
<br />
BP Ventures
![BP Ventures]()
The world is changing fast and our industry is changing with it. The energy mix is shifting towards lower carbon sources, driven by technological advances and growing environmental concerns. In bp, we will help drive this transition - and our business will be transformed by it. We are continually looking for talented, committed and ambitious people to help us shape the face of energy for the future.
BPE Private Equity GmbH
BPE Unternehmensbeteiligungen G.m.b.H. is a private equity firm specializing in investments in small management buyouts or buy ins and add-on acquisitions in small and medium-sized companies (SMEs or small and mid-caps) and private corporate businesses. It does not invest in venture capital stages and companies in the early phase including seed capital and start-up.
